CHICAGO -- Treatment with the CDK4/6 inhibitor abemaciclib (Verzenio) offered a dramatic survival uptick in a highly aggressive soft-tissue cancer that rarely responds to chemotherapy, according to the SARC041 trial....

CHICAGO -- The adjuvant treatment of RET fusion-positive non-small-cell lung cancer (NSCLC) following potentially curative surgery or radiotherapy has a new standard of care, researchers reported here. In a phase...

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold. Medscape Medical News Source link : https://www.medscape.com/viewarticle/abemaciclib-slows-progression-advanced-liposarcoma-2026a1000i2g?src=rss Author : Publish date...

Peptides have moved from bodybuilding forums into the cultural mainstream. Telehealth clinics advertise them for weight loss and recovery, often outside any FDA-approved indication. Podcasters describe their personal protocols to...

CHICAGO -- Men with metastatic castration-sensitive prostate cancer (mCSPC) and DNA repair alterations had significantly longer progression-free survival (PFS) with a targeted drug plus an androgen receptor pathway inhibitor (ARPI),...

Experts at the Primary Care Show identified the key barriers to lipid management — and what clinicians can do about them. Medscape News UK Source link : https://www.medscape.com/viewarticle/tackling-barriers-lipid-management-primary-care-2026a1000i26?src=rss Author :...

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC. Medscape Medical News Source link...

CHICAGO -- RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer. The phase III study showed that second-line daraxonrasib, an investigational oral RAS(ON)...

Rochelle Lewis is among more than 170 million woman globally to be diagnosed with PCOS. Source link : https://www.bbc.com/news/articles/cd9p50j3ljko?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-31 06:13:00 Copyright for syndicated content...

CHICAGO -- Adding an investigational TROP2-targeted antibody-drug conjugate (ADC) to first-line immunotherapy for PD-L1-positive non-small cell lung cancer (NSCLC) reduced the risk of disease progression and may have improved survival...

When an oncologist learns one patient’s story, everything shifts, including his approach to consultations. Medscape Medical News Source link : https://www.medscape.com/viewarticle/doctor-helps-woman-stop-blaming-herself-and-accept-treatment-2026a1000i20?src=rss Author : Publish date : 2026-05-30 20:22:00 Copyright for...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech...

Patients in full remission from endometrial cancer who underwent fertility-preserving treatment before cancer treatment had less IVF success than matched controls.The question remains as to what exactly drives this difference...

I have spent 20 years working in out-of-network healthcare reimbursement. After reading the New York Times article "A $440,000 Breast Reduction? How Doctors Cash In on a Health Care Law,"...

CHICAGO -- Combining two targeted therapies with standard-of-care chemotherapy extended progression-free survival (PFS) in patients with newly diagnosed B-cell lymphomas, according to data from the frontMIND trial. In the phase...

President Donald Trump on Friday gave his endorsement to a January study by HHS that calls for cutting the number of vaccines recommended for every American child. An executive order...

Editor's Note: This story includes discussion of suicide. If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or...

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection....

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain. Medscape Medical News...

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions. Medscape Medical...